1 / 32

Asma Yahyouche  Biomaterials Group Department of Materials, University of Oxford Parks Road, Oxford, OX1 3PH, UK

Biomaterials Science at Oxford. Tissue Engineering: a new healthcare technology. Asma Yahyouche  Biomaterials Group Department of Materials, University of Oxford Parks Road, Oxford, OX1 3PH, UK. Biomaterials.

truly
Download Presentation

Asma Yahyouche  Biomaterials Group Department of Materials, University of Oxford Parks Road, Oxford, OX1 3PH, UK

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Biomaterials Science at Oxford Tissue Engineering: a new healthcare technology Asma Yahyouche  Biomaterials Group Department of Materials, University of Oxford Parks Road, Oxford, OX1 3PH, UK

  2. Biomaterials • Biomaterials science may be the most multidisciplinary of all the sciences which encompasses aspects of medicine, biology, chemistry, engineering and materials science. • Biomaterials are : “Non-viable materials used in a medical devices intended to interact with biological systems” [D.F. Williams, 1987]

  3. Biomaterials: Examples • Joint replacements • Bone plates • Bone cement • Hip Joint • Artificial ligaments and tendons • Dental implants for tooth fixation • Blood vessel prostheses • Heart valves • Skin repair devices • Cochlear replacements • Contact lenses Hip joint Heart valve Knee joint Skin

  4. Biomaterials Group Materials Dept. Drug Delivery Systems Nano-SIMS characterization of Teeth Tissue Engineering In vitro Testing Cell culture Tissue expander Biomaterials at Oxford

  5. Human Tissue Damage • Disease (e.g cancer, infection). • Trauma (e.g accidental, surgery). • Congenital abnormalities (e.g birth defects). • Current clinical treatment based on: Grafts and Transplants ArtificialBiomaterials

  6. Organ transplant • High cost : $400B in USA each year US: 1July 2001- 30 June 2002 [Cooper .T (1987): Human Organ Transplantation: Societal, medical-legal, regulatory, and Reimbursement Issues ed. Cowen D.H et al, Health Administration Press Ann Arbor, MI, pp. 19-26]

  7. Example: Bone Fractures in UK • Bone is second transplanted tissue after blood. • Healthcare in the United Kingdom alone set to cost over 900£ million each year. • Each year in the UK: 150,000 fractures due to osteoporosis • Hip fracture is associated with high morbidity and mortality. • 30-50% of these hip operations with require subsequent revision surgery.

  8. Total Hip Joint Replacement • 50,000 hip replacements (arthroplasties) in Britain each year. • Hydroxyapatite porous coatings in orthopaedic prostheses: Bioactivity, Osteoconductivity. • Problem: Infections in orthopedic surgery (10% of cases)

  9. Biomaterials • Prostheses have significantly improved the quality of life for many ( Joint replacement, Cartilage meniscal repair, Large diameter blood vessels, dental) • However, incompatibility due to elastic mismatch leads to biomaterials failure.

  10. Conclusion • Tissue loss as a result of injury or disease, in an increasing ageing population, provide reduced quality of life for many at significant socioeconomic cost. • Thus a shift is needed from tissue replacement to tissue regeneration by stimulation the body’s natural regenerative mechanisms.

  11. TissueEngineering • National Science Foundation first defined tissue engineering in 1987 as “ an interdisciplinary field that applies the principles of engineering and the life sciences towards the development of biological substitutes that restore, maintain or improve tissue function”

  12. Tissue engineering • Potential advantages: • unlimited supply • no rejection issues • cost-effective

  13. Biopsy Nutrients, Growth Factors Human Cell Suspension Scaffold electrical stimuli chemical stimuli H Bioreactor system Implantation operation mechanical stimuli

  14. A 3D substrate that is key component of tissue engineering It needs to fulfil a number of requirement: - Controllably Porous structure - Interconnecting porosity - Appropriate surface chemistry - Appropriate mechanical properties - Biodegradable material - Tailorable Scaffolds

  15. Scaffolds Materials • Synthetic polymers: Aliphatic polyesters such as polyglycolic acid (PGA), polylactic acid ( PLLA), copolymers ( PLGA) and polycaprolactone ( PCL) are commonly used in tissue engineering. • Natural polymers: Most popular natural polymer used in tissue engineering is collagen.

  16. Synthetic polymers • More controllable from a compositional and materials processing viewpoint. • Scaffold architecture are widely recognized as important parameters when designing a scaffold • They may not be recognized by cells due to the absence of biological signals.

  17. Natural polymers • Natural materials are readily recognized by cells. • Interactions between cells and biological ECM are catalysts to many critical functions in tissues • These materials have poor mechanical properties.

  18. Cells Chen and Mooney Pharmaceutical Research, Vol. 20, No. 8, August 2003.

  19. Cells

  20. Growth factors [3H] thymidine uptake of chondrocytes encapsulated in collagen/chitosan/GAG scaffolds with and without TGF-β1 microspheres (S, S-TGF). Cumulative TGF-β1 release from chitosan microspheres. J.E. Lee et al. / Biomaterials 25 (2004) 4163–4173

  21. Oxford Biomaterials group • Collagen • Rapid prototyping: 3D wax printer

  22. Why collagen? • It is the ideal scaffold material: • is an important ECM molecule and is the major structural component in the body. • posses ideal surface for cell attachment in the body. • biocompatible and degrades into harmless products that are metabolized or excreted. • a very poor antigen , non-toxic.

  23. Collagen processing • This technique allow the control over pore size and porosity. • Achieved through variation of freezing temperature and collagen dispersion concentration Dry collagen scaffold

  24. Indirect Solid Freeform fabrication (ISFF) Computer Aided Design

  25. 1 2 Jet Head Mill Negative mould Dissolve away biosupport Elevator Negative mould fabrication process Collagen/HA casting Freezing at -30°C Scaffold Critical Point Drying Removal of BioBuild AutoCAD design Collagen scaffold fabrication

  26. 3-D printing From Dr. Chaozong Liu Printing video

  27. Tissue engineering scaffold: controlled architecture Featured with: • Pre-defined channels; with highly porous structured matrix; • With suitable chemistry for tissue growth – Collagen or HA • No toxic solvent involved, it offers a strong potential to integrate cells/growth factors with the scaffold fabrication process. From Dr. Terry Socholas

  28. Advantages of ISFF • Control of the external structure: Technology: CT/MRI CAD

  29. Heart valve tissue engineering Collagen scaffold of heart valve Valve cells Heart valve post- implantation

  30. Design Scaffolds with microchannels

  31. Aclian Blue staining revealed that extensive chondrogenesis were produced along the channels. Sirius Red staining revealed collagens production ( osteogenesis) in the periphery. hMSCs seeded channelled collagen scaffold stained with Sirius Red and Alcian Blue SEM images of scaffolds with channels and open porosity.

  32. Take home message • Biomaterials are materials interact with biological tissue • It’s a multi-disciplinary subject • Important application include • efficient drug delivery in the body • Development of artificial tissue replacement similar to the original for clinical use • By tracking elemental fluctuation archaeology information can be revealed

More Related